RegisterLogin

GRL0617

CAT: 0804-HY-117043-01Size: 5 mgDry Ice: NoHazardous: No
CAT#: HY-117043-01Size: 5 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
GRL0617 is a selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLpro), with an IC50 of 0.6 μM and a Ki value of 0.49 μM. GRL0617 also inhibits SARS-CoV with an EC50 of 14.5 μM. GRL0617 can be used for the research of severe acute respiratory syndrome[1].
CAS Number
[1093070-16-6]
Product Name Alternative
8-Nitrotryptanthrin
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Deubiquitinase; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/grl-0617.html
Concentration
10mM
Purity
99.62
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](C1=C2C=CC=CC2=CC=C1)C)C3=CC(N)=CC=C3C
Molecular Formula
C20H20N2O
Molecular Weight
304.39
Precautions
H302, H315, H319, H335
References & Citations
[1]Ratia K, et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A. 2008 Oct 21;105 (42) :16119-24.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-149720-01GRL018-21

Alternative Products

CatalogName
MBS5753225GRL0617
MBS3611741-01GRL0617
M21770-01GRL0617
MBS3843240-01GRL0617
T11464-01GRL0617
BUP12825-01GRL0617
593151GRL0617
C12264-01GRL0617
A18780-10GRL0617 10mg
A18780-25GRL0617 25mg

Popular Products